Showing results (231-240 of 410) with videos related to

Sort By:
Pageof 41
Experimental Hematology|February 1, 1996
Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cellsM Eder, P Hemmati, U Kalina, et al.
Research in Virology|January 1, 1993
Decreased haematopoietic colony growth in long-term bone marrow cultures of HIV-positive patientsR G Geissler, O G Ottmann, K Kleiner, et al.
Leukemia|January 21, 2006
Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrationsT Burmeister, R Marschalek, B Schneider, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 26, 2007
Genomic imprinting of insulin-like growth factor 2 (IGF-2) in chronic synovitisB Möller, G Kerschbaumer, M Komor, et al.
Annals of Hematology|June 10, 1998
Comparison of toxicity and outcome in patients with acute myeloid leukemia treated with high-dose cytosine arabinoside consolidation after induction with a regimen containing idarubicin or daunorubicinG Seipelt, W K Hofmann, H Martin, et al.
European Journal of Haematology|June 8, 1999
Megakaryocytic growth in patients with refractory anemia is suppressed by treatment with interferon alphaW K Hofmann, U Kalina, G Seipelt, et al.
Onkologie|June 1, 1986
Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferonA Ganser, W Brücher, H R Brodt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Reproductive and endocrine gonadal functions in adults following multidrug chemotherapy for acute lymphoblastic or undifferentiated leukemiaE D Kreuser, W D Hetzel, W Heit, et al.
Klinische Padiatrie|April 20, 2012
[GATA1-mutation associated leukemia in children with trisomy 21 mosaic]D Reinhardt, K Reinhardt, C Neuhoff, et al.
Leukemia|November 24, 2005
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trialsU Creutzig, M Zimmermann, J Ritter, et al.
Pageof 41